Close Mobile Navigation

HELP PROTECT YOURSELF AGAINST CERTAIN HPV-RELATED CANCERS AND DISEASES WITH GARDASIL®9

GARDASIL®9 is the first and only vaccine that helps protect individuals aged 9–45 against 9 human papillomavirus (HPV) types that can cause certain cancers & diseases.

For men and women aged 9–45

How to get vaccinated

Connect with a healthcare professional today to discuss HPV vaccination and find a vaccination site near you. You can also follow our step-by-step guide on how to get GARDASIL®9.

Who should get vaccinated

About 75% of sexually active Canadians will have at least one HPV infection during their lifetime.

Many people who have HPV don’t even realize it because the infection often has no signs or symptoms – which means they can pass on the virus to others without knowing it.

All eligible individuals aged 9 through 45 should consider getting GARDASIL®9 to help protect themselves against genital warts and certain HPV-related cancers.

Women

HPV causes nearly 100% of cervical cancer cases as well as other cancers & diseases.

Learn more

Men

Certain HPV types can lead to HPV-related cancers & genital warts in men.

Learn more

Children

Vaccinating your child now can help protect them against certain HPV-related cancers & diseases in the future.

Learn more

Students

It is estimated that every 15 minutes, one Canadian develops genital warts.

Learn more

You may be covered!

PROVINCIAL PROGRAMS

Public coverage for GARDASIL®9 is available and varies by province or territory, and by age or risk factors.

PRIVATE INSURANCE COVERAGE

You may have private health insurance through work or school. Many private insurance plans reimburse some or all of the cost of GARDASIL®9.

Know the facts

Safety Information

GARDASIL®9 is a vaccine indicated for individuals 9 through 45 years of age for the prevention of infection caused by the human papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, 45, 52 and 58 and the following diseases associated with the HPV types included in the vaccine: certain head and neck cancers, such as throat and back of mouth cancers, caused by HPV types 16, 18, 31, 33, 45, 52, and 58. GARDASIL®9 has been approved with conditions. This means it has passed Health Canada’s review and can be bought and sold in Canada, but the manufacturer has agreed to complete more studies to make sure the vaccine works the way it should. For more information, talk to your healthcare professional.

GARDASIL®9 is also indicated for individuals 9 through 45 years of age for the prevention of infection caused by the human papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, 45, 52 and 58 and the following diseases associated with the HPV types included in the vaccine: cervical, vulvar, vaginal and anal cancer caused by HPV types 16, 18, 31, 33, 45, 52, and 58; genital warts (condyloma acuminata) caused by HPV types 6 and 11; abnormal and precancerous cervical lesions (changes in cells of the cervix that have a risk of turning into cancer) as found in a Pap test caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58; abnormal and precancerous vaginal, vulvar (outside of the female genital area) and anal lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58.

GARDASIL®9 does not protect the person getting the vaccine from a disease that is caused by other types of HPV, other viruses, or bacteria, and from HPV types that he/she may already have; but most people do not have all types contained in the vaccine. GARDASIL®9 does not treat HPV infection, cancers and diseases, or prevent its complications. GARDASIL®9 may not fully protect each person who gets it. GARDASIL®9 does not remove the need for screening for cervical, vulvar, vaginal, anal, and certain head and neck cancers, such as throat and back of mouth cancers; women should still get routine cervical cancer screening. GARDASIL®9 is not recommended for use in pregnant women and should only be used during pregnancy if a doctor or healthcare professional decides it is clearly needed. Women who become pregnant before completion of the vaccine series should complete their vaccination schedule after childbirth. If you are breastfeeding, talk to your doctor or healthcare professional. GARDASIL®9 may cause some side effects and allergic reactions. The most common side effects seen are pain, swelling, redness, itching, bruising, bleeding, a lump where the shot is given, headache, fever, nausea, dizziness, tiredness, diarrhea, abdominal pain and sore throat. Fainting can happen after getting an HPV vaccine. Signs of an allergic reaction may include difficulty breathing, wheezing (bronchospasm), hives and rash. This is not a complete list of side effects; for any unexpected effects while taking GARDASIL®9, contact your doctor or pharmacist. Contact your doctor or healthcare professional to determine if GARDASIL®9 is an appropriate option for you.

Information about GARDASIL®9 is provided in the Product Monograph and Consumer Information, available here.

HPV=human papillomavirus.

This field is for validation purposes and should be left unchanged.